Ingredion Insider Filing Shows Routine 290-Share Board Retainer Grant

Rhea-AI Filing Summary

Ingredion Incorporated (INGR) filed a Form 4 showing that outside director Patricia Verduin received 290 shares of common stock on 30 June 2025. The shares, valued at $137.48 each, were issued under the company’s standard annual retainer program for non-employee directors and were coded “A” (acquisition) rather than an open-market purchase. After the grant, Verduin’s direct holdings rose to 2,751 shares. No derivative securities were involved, and no other insiders were listed on the filing. Because the award is routine board compensation and represents a market value of roughly $40,000—immaterial relative to Ingredion’s market capitalization—the transaction is unlikely to influence the company’s financial outlook or share price.

Positive

• Director’s stake increased, modestly aligning board incentives with shareholder interests.

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine 290-share grant to director; negligible financial or market impact.

The Form 4 discloses a standard equity retainer, not an open-market buy or sell. While insider acquisitions can sometimes be construed as bullish, the small size (≈$40k) and automatic nature of this grant limit its signaling value. The filing neither alters Ingredion’s capital structure nor conveys new information about operational performance, so investors can treat it as a procedural disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Verduin Patricia

(Last) (First) (Middle)

5 WESTBROOK CORPORATE CENTER

(Street)

WESTCHESTER IL 60154

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ingredion Inc [ INGR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2025		A		290(1)	A	$137.48	2,751	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These are shares of common stock issued to the Company's outside directors as part of their annual retainer.

	Michael N. Levy, attorney-in-fact	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Ingredion (INGR) shares did Director Patricia Verduin receive?

She was issued 290 shares of common stock.

What was the transaction price reported on the Form 4?

The deemed price was $137.48 per share.

What is Patricia Verduin’s total direct ownership after the grant?

Her holdings increased to 2,751 shares of INGRedion common stock.

Was this an open-market purchase or a compensation grant?

It was a compensation-related equity grant under the annual director retainer.

Does the filing signal any major strategic change at Ingredion?

No. The transaction is routine and does not indicate strategic shifts or operational updates.